eHealth, Inc.
EHTHNasdaqCIK 1333493FinancialsFiscal year ends Dec 31
Reports and events: 320 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1620:10 ET | 8-K | 3.01 Delisting notice | 0001333493-26-000040 |
| 2026-08-0520:23 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001333493-26-000036 |
| 2026-08-0420:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-26-000033 |
| 2026-06-2520:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001333493-26-000029 |
| 2026-05-0721:45 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001333493-26-000027 |
| 2026-05-0620:18 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001333493-26-000025 |
| 2026-04-2820:16 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001333493-26-000020 |
| 2026-03-3120:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001333493-26-000014 |
| 2026-02-2621:14 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001333493-26-000010 |
| 2026-02-2521:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-26-000007 |
| 2026-01-0613:43 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001333493-26-000003 |
| 2025-12-1813:44 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001333493-25-000115 |
| 2025-11-0622:56 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001333493-25-000111 |
| 2025-11-0521:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-25-000110 |
| 2025-10-0720:42 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001333493-25-000106 |
| 2025-09-1920:13 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001333493-25-000101 |
| 2025-08-0720:23 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001333493-25-000094 |
| 2025-08-0611:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-25-000087 |
| 2025-07-2913:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001333493-25-000083 |
| 2025-06-2420:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001333493-25-000078 |
| 2025-05-0720:28 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001333493-25-000057 |
| 2025-05-0711:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-25-000054 |
| 2025-04-2820:05 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001333493-25-000047 |
| 2025-02-2722:24 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001333493-25-000027 |
| 2025-02-2612:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-25-000023 |
| 2024-12-1713:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001333493-24-000185 |
| 2024-11-0621:25 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001333493-24-000173 |
| 2024-11-0612:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-24-000170 |
| 2024-11-0120:26 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001333493-24-000165 |
| 2024-10-0920:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001333493-24-000155 |
| 2024-09-2420:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001333493-24-000149 |
| 2024-08-0720:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001333493-24-000126 |
| 2024-08-0711:38 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001333493-24-000122 |
| 2024-06-1420:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001333493-24-000106 |
| 2024-05-3020:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001333493-24-000085 |
| 2024-05-0720:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001333493-24-000074 |
| 2024-05-0711:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-24-000072 |
| 2024-04-2620:06 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0001333493-24-000066 |
| 2024-02-2921:28 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001333493-24-000032 |
| 2024-02-2712:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-24-000029 |
| 2024-01-2613:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-24-000018 |
| 2023-11-2021:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001333493-23-000149 |
| 2023-11-0922:56 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001333493-23-000141 |
| 2023-11-0821:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-23-000140 |
| 2023-08-0820:22 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001333493-23-000113 |
| 2023-08-0811:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-23-000110 |
| 2023-07-1020:32 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-184655 |
| 2023-06-2120:15 ET | 8-K | 5.07 Shareholder vote results | 0001333493-23-000095 |
| 2023-05-0920:36 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001333493-23-000063 |
| 2023-05-0911:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-23-000060 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.